These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31821813)

  • 21. Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries.
    Mahfoud F; Tunev S; Ruwart J; Schulz-Jander D; Cremers B; Linz D; Zeller T; Bhatt DL; Rocha-Singh K; Böhm M; Melder RJ
    Circ Cardiovasc Interv; 2014 Dec; 7(6):813-20. PubMed ID: 25336466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on intervention versus medical therapy for atherosclerotic renal artery stenosis.
    Mousa AY; AbuRahma AF; Bozzay J; Broce M; Bates M
    J Vasc Surg; 2015 Jun; 61(6):1613-23. PubMed ID: 26004332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. To intervene or not? A man with multidrug-resistant hypertension, endovascular abdominal aneurysm repair, bilateral renal artery stenosis and end-stage renal disease salvaged with renal artery stenting.
    Sarafidis PA; Stavridis KC; Loutradis CN; Saratzis AN; Pateinakis P; Papagianni A; Efstratiadis G; Saratzis N
    Blood Press; 2016; 25(2):123-8. PubMed ID: 26581234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of stent failure in a patient with fibromuscular dysplasia following renal artery stenting.
    Wang LC; Scott DJ; Clemens MS; Hislop SJ; Arthurs ZM
    Ann Vasc Surg; 2015 Jan; 29(1):123.e19-21. PubMed ID: 25192822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.
    Jaff MR; Bates M; Sullivan T; Popma J; Gao X; Zaugg M; Verta P;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):343-50. PubMed ID: 22511402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of translesional pressure gradient and pharmacological provocation for the assessment of intermediate renal artery disease.
    Jones NJ; Bates ER; Chetcuti SJ; Lederman RJ; Grossman PM
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):429-34. PubMed ID: 16892443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal artery stenosis.
    Safian RD
    Prog Cardiovasc Dis; 2021; 65():60-70. PubMed ID: 33745915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment?
    Iwashima Y; Ishimitsu T
    Hypertens Res; 2020 Oct; 43(10):1015-1027. PubMed ID: 32572170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherosclerotic renal artery stenosis and renovascular hypertension: clinical diagnosis and indications for revascularization.
    Kerut EK; Geraci SA; Falterman C; Hunter D; Hanawalt C; Giles TD
    J Clin Hypertens (Greenwich); 2006 Jul; 8(7):502-9. PubMed ID: 16849904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "The challenge facing renal artery revascularization: what have we not proven and why we must"?
    Hynes BG; Margey R; Moran D; Ruggiero NJ; Kiernan TJ; Jaff MR
    Acta Chir Belg; 2010; 110(6):575-83. PubMed ID: 21337836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful endovascular treatment of chronic renal artery occlusion: a preliminary retrospective case series including 15 patients.
    Yang M; Lin L; Niu G; Yan Z; Zhang B; Tong X; Zou Y
    Int Urol Nephrol; 2019 Feb; 51(2):285-291. PubMed ID: 30607776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.
    Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF
    J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renovascular hypertension.
    Dietz R
    Contrib Nephrol; 1984; 43():129-43. PubMed ID: 6237882
    [No Abstract]   [Full Text] [Related]  

  • 34. Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial.
    Chrysant GS; Bates MC; Sullivan TM; Bachinsky WB; Popma JJ; Peng L; Omran HL; Jaff MR;
    J Clin Hypertens (Greenwich); 2014 Jul; 16(7):497-503. PubMed ID: 24909590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and optimal management in patients with renal artery stenosis.
    Piecha G; Wiecek A; Januszewicz A
    J Nephrol; 2012; 25(6):872-8. PubMed ID: 23023722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal Artery Stenosis: Optimal Therapy and Indications for Revascularization.
    Patel SM; Li J; Parikh SA
    Curr Cardiol Rep; 2015 Sep; 17(9):623. PubMed ID: 26238738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis and management of renovascular hypertension and ischemic nephropathy.
    Yerram P; Karuparthi PR; Chaudhary K
    Minerva Urol Nefrol; 2012 Mar; 64(1):63-72. PubMed ID: 22402318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal Artery Stenosis: To Stent or Not to Stent.
    Ibrahim HN
    Methodist Debakey Cardiovasc J; 2018; 14(1):68. PubMed ID: 29623176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SCAI expert consensus statement for renal artery stenting appropriate use.
    Parikh SA; Shishehbor MH; Gray BH; White CJ; Jaff MR
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1163-71. PubMed ID: 25138644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten-year experience with renal artery in-stent stenosis.
    Stone PA; Campbell JE; Aburahma AF; Hamdan M; Broce M; Nanjundappa A; Bates MC
    J Vasc Surg; 2011 Apr; 53(4):1026-31. PubMed ID: 21215576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.